Powered by

-Galectin Therapeutics to Present at the 2nd Annual Anti-Fibrotic Drug Development Summit

Nov 20, 2018 - ENP Newswire

NORCROSS - Galectin Therapeutics Inc.(NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today announced that Dr. Harold H. Shlevin, the Company's President and CEO, will present at the 2nd Annual Anti-Fibrotic Drug Development Summit (AFDD) at the Hyatt Regency Cambridge in Massachusetts on Thursday, November 29, at 2:00 p.m. EST.

In his presentation, titled 'Physiological Control Systems Involving Galectins in the Treatment of Diseases,' Dr. Shlevin will ...